COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,141 Articles (22,693 medRxiv, 8,448 bioRxiv)

Most recent first Previous |  Page 166: Articles 1651-1660  | Next

SARS-CoV-2 genomic surveillance from community-distributed rapid antigen tests
Emmen, I. E., Vuyk, W. C., Lail, A. J., Wolf, S., O'Connor, E. J., Dalvie, R., Bhasin, M., Virdi, A., White, C., Hassan, N. R., Richardson, A., VanSleet, G., Weiler, A. M., Rounds-Dunn, S., Van Horn, K., Gartler, M., Jorgenson, J., Spelman, M., Ottosen, S., Minor, N. R., Wilson, N., Friedrich, T., O'Connor, D.
10.1101/2024.08.12.24311680 — Posted: 2024-08-14
Severe acute respiratory syndrome (SARS) mathematical models and disease parameters: a systematic review and meta-analysis
Morgenstern, C., Rawson, T., Routledge, I., Kont, M., Imai-Eaton, N., Skarp, J. E., Doohan, P., McCain, K., Johnson, R., Unwin, H. J. T., Naidoo, T., Dee, D. P., Parchani, K., Cracknell Daniels, B. N., Vicco, A., Drake, K. O., Christen, P., Sheppard, R. J., Leuba, S. I., Hicks, J. T., McCabe, R., Nash, R. K., Santoni, C. N., Pathogen Epidemiology Review Group, , Cuomo-Dannenburg, G., van Elsland, S., Bhatia, S., Cori, A.
10.1101/2024.08.13.24311934 — Posted: 2024-08-14
Using quantitative bias analysis to adjust for misclassification of COVID-19 outcomes: An applied example of inhaled corticosteroids and COVID-19 outcomes
Bokern, M., Rentsch, C. T., Quint, J. K., Hunnicutt, J., Douglas, I. J., Schultze, A.
10.1101/2024.08.13.24311341 — Posted: 2024-08-14
Consent to Recontact for Future Research Using Linked Primary Healthcare Data: Outcomes and General Practice Perceptions from the ATHENA COVID-19 Study
Greaves, K., King, A., Bourne, Z., Welsh, J., Morgan, M., Tolosa, M. X., Johnston, T., Bonner, C., Stanton, T., Korda, R.
10.1101/2024.08.13.24311963 — Posted: 2024-08-14
Survey: Accessibility of At-Home COVID-19 Tests for Users with Disabilities
Farmer, S., Peagler, A., Sheiner, R., Martinez, A., Razin, V.
10.1101/2024.08.13.24311938 — Posted: 2024-08-14
Torsional Twist of the SARS-CoV and SARS-CoV-2 SUD-N and SUD-M domains
Rosas-Lemus, M., Minasov, G., Brunzelle, J. S., Taha, T. Y., Lemak, S., Yin, S., Shuvalova, L., Rosecrans, J., Khanna, K., Seifert, H. S., Savchenko, A., Stogios, P. J., Ott, M., Satchell, K. J.
10.1101/2024.08.13.607777 — Posted: 2024-08-14
How does policy modelling work in practice? A global analysis on the use of modelling in Covid-19 decision-making
Hadley, L., Rich, C., Tasker, A., Restif, O., Funk, S.
10.1101/2024.08.12.24311899 — Posted: 2024-08-13
Effectiveness of XBB.1.5 monovalent COVID-19 vaccine against COVID-19 mortality in Australians aged 65 years and older during August 2023 to February 2024
Liu, B., Scaria, A., Stepien, S., Macartney, K.
10.1101/2024.08.12.24311895 — Posted: 2024-08-13
Pemivibart is less active against recent SARS-CoV-2 JN.1 sublineages
Wang, Q., Guo, Y., Ho, J., Ho, D. D.
10.1101/2024.08.12.607496 — Posted: 2024-08-13
Avoided and avoidable deaths with the use of COVID-19 convalescent plasma in Italy during the first two years of pandemic
Franchini, M., Casadevall, A., Dragotakes, Q., Focosi, D.
10.1101/2024.08.12.24311864 — Posted: 2024-08-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).